BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1354910)

  • 41. Current trends in the pharmacotherapy for peptic ulcer disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 44. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents].
    Bartolotta M; Carditello A
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nosocomial lung infections. Epidemiology and problems of stress ulcer prevention].
    Geroulanos S; Attinger B; Decurtins M; Buchmann P
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1063-8. PubMed ID: 1983487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of H2-receptor antagonists.
    Iberti TJ
    DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gastroduodenal ulcers resistant to medical treatment].
    Miazza B
    Rev Med Suisse Romande; 1989 May; 109(5):361-3. PubMed ID: 2568674
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical effect of dopamine on incidence of peptic ulceration.
    Schwedes U; Paschke R; Schille M; Usadel KH
    Klin Wochenschr; 1986; 64 Suppl 7():128-31. PubMed ID: 2882049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Stress ulcer; origin and treatment (author's transl)].
    Koelsch KA
    Zentralbl Chir; 1976; 101(23):1409-19. PubMed ID: 65066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management of gastrointestinal mucosal damage in patients with cerebrovascular disease].
    Kawakubo K; Fujishima M
    Nihon Rinsho; 2002 Aug; 60(8):1573-9. PubMed ID: 12187753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical concept of acute and chronic peptic ulcers].
    Oshiba S; Asada S
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):27-30. PubMed ID: 1673702
    [No Abstract]   [Full Text] [Related]  

  • 56. Stress ulcer prevention and histamine-2-receptor antagonists: leaps of faith or back to the drawing board?
    Freedman MD
    Crit Care Med; 1999 Jan; 27(1):13-4. PubMed ID: 9934877
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of peptic ulcer and chronic pancreatitis].
    Ruppin H
    Fortschr Med; 1977 Feb; 95(5):305-9. PubMed ID: 14065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acid suppression in critically ill patients: what does the evidence support?
    Spirt MJ
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Digestive stress hemorrhage. Physiopathology and prevention].
    Malledant Y; Tanguy M; Saint-Marc C
    Ann Fr Anesth Reanim; 1989; 8(4):334-46. PubMed ID: 2573302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey.
    Wyncoll DL; Roberts PC; Beale RJ; McLuckie A
    BMJ; 1997 Apr; 314(7086):1013. PubMed ID: 9112846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.